Document Detail

Voice changes after androgen therapy for hypogonadotrophic hypogonadism.
MedLine Citation:
PMID:  15475787     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES/HYPOTHESIS: Males with isolated hypogonadotropic hypogonadism (IHH) fail to undergo normal sexual development, including the lack of masculinization of the larynx. The objective of this study was to measure the mean vocal fundamental frequency (MF0) in IHH patients and determine the impact of androgen treatment. An additional aim was to compare the MF0 between IHH patients and controls. STUDY DESIGN: Prospective observational study. METHODS: Twenty-four patients with IHH were identified along with 30 normal males and females. Voice recordings were obtained on all subjects. Androgen therapy was administered to the IHH patients. The MF0 and serum sex hormone levels were measured before treatment and at intervals during therapy. These results were compared with the pretreatment data within the IHH group. Voice parameters were also compared between the pre- and posttreatment IHH patients and the normal males and females. RESULTS: The MF0 in untreated IHH patients was 229 +/- 41 Hz. This was intermediate between the normal male (150 +/- 22 Hz, P < .001) and normal female patients (256 +/- 29 Hz, P < .01). After treatment, the MF0 in the IHH group decreased to 173 +/- 30 Hz (P < .0001); indeed, their posttreatment MF0 approached that of normal males (P < .08). Serum hormone levels responded to the injected testosterone, but these levels did not directly correlate with MF0. CONCLUSIONS: MF0 in IHH patients is intermediate between normal male and female levels. After treatment with testosterone, these values approach the range of normal males. This prospective study details the impact of androgens on the larynx and vocal function in patients with IHH.
Timur Akcam; Erol Bolu; Albert L Merati; Coskun Durmus; Mustafa Gerek; Yalcin Ozkaptan
Related Documents :
7827217 - Thyrotropin response to trh stimulation in depressed patients with autoimmune thyroiditis.
2592737 - Evaluation of metabolic status in amiodarone-induced thyroid disorders: plasma coenzyme...
21257827 - High frequency of silent pulmonary embolism in patients with cryptogenic stroke and pat...
2614007 - Circadian and pulsatile thyrotropin release in treated acromegalics.
3181187 - Tc-99m-ida gallbladder kinetics and response to cck in chronic cholecystitis.
21552667 - Respiratory outcomes and atopy in school-age children who were preterm at birth, with a...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  The Laryngoscope     Volume:  114     ISSN:  0023-852X     ISO Abbreviation:  Laryngoscope     Publication Date:  2004 Sep 
Date Detail:
Created Date:  2004-10-11     Completed Date:  2004-10-22     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8607378     Medline TA:  Laryngoscope     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1587-91     Citation Subset:  IM    
Department of Otolaryngology-Head and Neck Surgery, Gulhane Military Medical Academy, Ankara, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Androgens / blood,  therapeutic use*
Follicle Stimulating Hormone / blood,  deficiency*
Follow-Up Studies
Hypogonadism / blood,  drug therapy*
Luteinizing Hormone / blood,  deficiency*
Prospective Studies
Reference Values
Sex Characteristics
Sexual Maturation / drug effects
Sound Spectrography*
Testosterone / blood,  therapeutic use*
Voice Quality / drug effects*
Reg. No./Substance:
0/Androgens; 58-22-0/Testosterone; 9002-67-9/Luteinizing Hormone; 9002-68-0/Follicle Stimulating Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Nasopharyngeal pH monitoring in chronic sinusitis patients using a novel four channel probe.
Next Document:  Microaspiration in infants with laryngomalacia.